ABA Chemicals Corp (300261) – tečaj delnic in novice

ABA Chemicals, also known as Abachem, is a Chinese chemical manufacturing company headquartered in Taicang. The company was founded in 2006 as Suzhou ABA Chemicals, and is traded on the Shenzhen Stock Exchange as 300261. The company provides contract development and manufacturing services to the pharmaceutical, biotechnological, and agrochemical industries. It offers various services for the production of fine chemicals; intermediates; and active pharmaceutical ingredients. The company also provides unnatural amino acids, pyrazoles, triazoles, and azaindoles, as well as producing an intermediate of API Levetiracetam for the treatment of epilepsy. The company is also involved in pesticide manufacturing intermediates, and acquired the Chinese firm Shanghai Puyi Chemical to consolidate its position in this market. It also acquired Amino Chemicals, a pharmaceutical API intermediate manufacturer and member of the Dipharma Group, in 2017; Amino is based on Malta and was established in 1992. ABA and Dipharma began a working partnership in the 1980s, which provided Dipharma access to the Chinese pharmaceutical market. Wikipedia

Vizitka: ABA Chemicals Corp

Generalni direktor-

Št. zaposlenih1,2 tis.

Ustanovljeno13. jan. 2006

Sedež-

SektorSpeciality chemicals

Spletno mestoabachem.com

Vse vrednosti v valuti CNY	sep. 2025	dec. 2025	mar. 2026	jun. 2026
Prihodek	334,69 mio.	310,82 mio.	303,59 mio.	293,25 mio.
Strošek prodanega blaga	248,45 mio.	300,89 mio.	286,91 mio.	289,14 mio.
Stroški materiala in storitev	248,45 mio.	300,89 mio.	286,91 mio.	289,14 mio.
Stroški raziskav in razvoja	29,18 mio.	28,68 mio.	20,19 mio.	22,86 mio.
Skupni stroški raziskav in razvoja	-	-	-	-
Stroški prodaje, splošni in administrativni stroški	48,48 mio.	37,47 mio.	41,02 mio.	41,59 mio.
Operativni strošek	81,42 mio.	103,89 mio.	62,77 mio.	66,53 mio.
Skupni operativni stroški	329,87 mio.	404,78 mio.	349,68 mio.	355,67 mio.
Prihodek iz poslovanja	4,82 mio.	−93,96 mio.	−46,09 mio.	−62,42 mio.
Drug prihodek, ki ne izhaja iz poslovanja	15,52 mio.	−16,13 mio.	−10,85 mio.	9,81 mio.
Zaslužek pred obdavčitvijo z vključenimi izrednimi postavkami	−2,79 mio.	−177,93 mio.	−73,15 mio.	−115,16 mio.
Zaslužek pred obdavčitvijo brez izrednih postavk	−1,61 mio.	−124,19 mio.	−66,74 mio.	−83,81 mio.
Odhodek iz obdavčitve dobička	−3,44 mio.	−6,13 mio.	−14,24 mio.	−13,04 mio.
Dejanska davčna stopnja	123,57 %	3,45 %	19,47 %	11,32 %
Drugi operativni stroški	2,79 mio.	−849,91 tis.	2,71 mio.	3,05 mio.
Čisti prihodek	1,75 mio.	−152,59 mio.	−57,58 mio.	−101,81 mio.
Neto stopnja dobička	0,52 %	−49,09 %	−18,97 %	−34,72 %
Čisti dobiček na delnico	-	-	-	-
Prihodki iz obresti in naložb	5,04 mio.	-	568,87 tis.	77,43 tis.
Obrestni odhodki	−9,72 mio.	−15,90 mio.	−10,37 mio.	−13,65 mio.
Neto obrestni odhodki	−4,68 mio.	−15,90 mio.	−9,80 mio.	−13,58 mio.
Stroški amortizacije	-	-	-	-
EBITDA	38,18 mio.	−59,20 mio.	−11,33 mio.	−28,50 mio.
Dobiček ali izguba pri prodaji sredstev	110,13 tis.	−161,52 tis.	-	−258,93 tis.

Vprašajte kar koli